Trial Profile
Safety and Efficacy of Metformin Glycinate vs Metformin Hydrochloride on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms COMET
- Sponsors Laboratorios Silanes
- 11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association.
- 26 Jan 2018 Status changed from active, no longer recruiting to completed.
- 19 Feb 2014 Planned End Date changed from 1 Feb 2014 to 1 Oct 2016, as per ClinicalTrials.gov record.